S.Amdt. 3193

SA 3193 is an amendment submitted by Mr. McConnell to be proposed to amendment SA 3038 and bill H.R. 3944. Its purpose is to amend the Agricultural Marketing Act of 1946 regarding the definitions and regulations of hemp.

The amendment aims to change or add the following to the bill:

• Definitions of Hemp and Industrial Hemp: It updates the definition of hemp to be the plant Cannabis sativa L. and its parts with a total tetrahydrocannabinol concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent on a dry weight basis. It defines industrial hemp as hemp grown for specific uses, such as the stalk, fiber, seeds, microgreens, or for research at independent research institutes or institutions of higher education.

• Exclusions: It specifies that hemp does not include viable seeds exceeding the 0.3 percent concentration threshold or hemp-derived cannabinoid products containing cannabinoids that are not naturally produced by the plant, those synthesized outside the plant, or those with quantifiable amounts of tetrahydrocannabinol or similar effect cannabinoids as determined by the Secretary of Health and Human Services.

• Hemp-derived Cannabinoid Products: It defines these as intermediate or final products derived from hemp (excluding industrial hemp) intended for human or animal use. It excludes drugs approved under specific sections of the Federal Food, Drug, and Cosmetic Act.

• Technical Corrections: It updates the language in Section 297B(e)(2)(A)(iii) of the Agricultural Marketing Act of 1946 to reference total tetrahydrocannabinol concentration (including tetrahydrocannabinolic acid) instead of just delta-9 tetrahydrocannabinol.

• Timeline and Reporting: These changes would take effect 1 year after the Act is enacted. Additionally, the Secretary of Agriculture and the Commissioner of Food and Drugs must provide a report to the Committees on Appropriations within 180 days regarding implementation, industry stakeholder engagement, projected marketplace impacts, and requirements for testing, labeling, packaging, and adverse event reporting.